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Background: Irritable bowel syndrome (IBS) and functional dyspepsia (FD) show considerable overlap and are both
associated with psychiatric comorbidity. The present study aimed to investigate whether IBS patients with FD show
higher levels of psychopathology than those without FD. As a preliminary analysis, it also evaluated the
psychopathological differences, if any, between IBS patients featuring the two Rome III-defined FD subtypes, i.e.
postprandial distress syndrome (PDS) and epigastric pain syndrome (EPS).
Methods: Consecutive outpatients (n = 82, F = 67, mean age 41.6 ± 12.7 years) referred to our third level
gastroenterological centre, matching the Rome III criteria for IBS and, if present, for concurrent FD, were recruited.
They were asked to complete a 90-item self-rating questionnaire, the Symptom Checklist 90 Revised (SCL-90-R), in
order to assess the psychological status. Comparisons between groups were carried out using the non-parametric
Mann-Whitney U test.
Results: Patients with IBS only were 56 (68.3%, F = 43, mean age 41.6 ± 13.3 years) and patients with both IBS and
FD were 26 (31.7%, F = 24, mean age 41.8 ± 11.5 years), 17 of whom had PDS and 9 EPS. Patients with both IBS
and FD scored significantly higher on the SCL-90-R GSI and on eight out of the nine subscales than patients with
IBS only (P ranging from 0.000 to 0.03). No difference was found between IBS patients with PDS and IBS patients
with EPS (P ranging from 0.07 to 0.97), but this result has to be considered provisional, given the small sample size
of the two subgroups.
Conclusions: IBS-FD overlap is associated with an increased severity of psychopathological features. This finding
suggests that a substantial subset of patients of a third level gastroenterological centre with both IBS and FD may
benefit from psychological assessment and treatment.
Background
Irritable bowel syndrome (IBS) and functional dyspepsia
(FD) are functional gastrointestinal disorders commonly
seen in both primary healthcare and gastroenterology
practice; they show a prevalence of, respectively, 10%-20%
[1] and 20%-30% [2] in the general population.
Recent epidemiological studies, conducted on the gen-
eral population as well as on patient-based series, demon-
strate considerable overlap between IBS and FD [3-5]:
a high percentage of IBS patients show coexisting upper
gastrointestinal symptoms consistent with FD (epigastric
pain, epigastric burning, postprandial fullness, early satia-
tion), and a high percentage of FD patients complain of
lower abdominal pain and disturbed bowel habits (diar-
rhea, constipation, mixed diarrhea and constipation).
In both IBS and FD there is evidence of an association
with psychological factors, and comorbidity with psychiatric
disorders, especially depression, anxiety and somatization,
is high [6,7]. It is unclear whether the co-occurrence of IBS
and FD impairs the psychological status to a greater degree
than the occurrence of IBS or FD alone. A number of stu-
dies support this hypothesis, having found that the presence
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increases the incidence and severity of psychopathology
[8,9]. However, a recent study seems to contradict these
findings [10]. Given that psychopathological features influ-
ence symptom perception, health-care seeking behavior
and quality of life in IBS patients [7,11], and that the pre-
sence of dyspeptic symptoms, in addition to the IBS ones,
may have a negative impact on psychopathological features,
it seems worthwhile to comparatively assess these features
in IBS patients with and without FD.
It is also unknown whether, in IBS patients with FD,
psychopathological features differ between patients with
the two subtypes of FD as defined by the Rome III criteria:
postprandial distress syndrome (PDS) and epigastric pain
s y n d r o m e( E P S )[ 2 ] .T oo u rk n o w l e d g e ,n os t u d yo nt h e
relationship between the subtype of FD in IBS patients
and psychiatric comorbidity has yet been reported. Since
PDS and EPS may have distinct underlying pathophysiol-
ogy [2,12], it seems of some interest to investigate whether
the two FD subtypes also present distinct psychopathologi-
cal features, thus determining different loads of psychiatric
comorbidity in IBS patients.
The aim of the present study was to determine whether
IBS patients with FD show higher levels of psychopathol-
ogy than those without FD. As a preliminary analysis, the
study also evaluated whether, in IBS patients with FD, the




Consecutive IBS outpatients (n = 82, F = 67, mean age
41.6 ± 12.7 years), referred to our third level gastroentero-
logical centre, were recruited. The majority of patients
(54.9%) were referred from primary care, whereas the
remainder were either self-referred (34.1%) or referred
from other gastroenterologists (11.0%). Patients were
interviewed by an experienced gastroenterologist. Age,
gender, medical history, including gastrointestinal and
extra-gastrointestinal complaints, and family history were
assessed. The diagnoses of IBS and, if present, of concur-
rent FD, were made on the basis of the Rome III criteria
[1,2] by means of a clinical interview and of a gastrointest-
inal symptom questionnaire [13]. IBS patients with FD
were classified according to their symptoms as having one
of the two subtypes of FD, PDS or EPS. All patients had
normal serum biochemistry, complete blood count and no
significant pathological findings at esophagogastroduode-
noscopy and colonoscopy. Patients with another coexisting
disease (e.g., malignancy; cardiovascular, pulmonary, hepa-
tic or renal disorder) were excluded. Patients meeting
enrollment criteria were asked to fill out a self-report
questionnaire, the Symptom Checklist 90 Revised (SCL-
90-R) [14], in order to assess psychopathological features.
The questionnaire was reviewed with each participant to
guarantee that they understood how to complete it. Ques-
tionnaires were completed anonymously; a numeric code
was assigned to each patient and then entered in a data-
base for statistical analysis. The aim of the study was thor-




Gastrointestinal symptoms were investigated by means of
the Italian version of the Rome II Modular Questionnaire
[13], consisting of 38 items specifically designed to estab-
lish the presence of functional gastrointestinal disorders;
in the present study we focused on the questions related
t ot h ep r e s e n c eo fI B Sa n dF D .T h eq u e s t i o n n a i r eh a s
been validated and approved for use in the Italian language
by the Multinational Working Team to Develop Criteria
for Functional Gastrointestinal Disorders and takes
approximately 15 minutes to be completed. Although the
Rome II Questionnaire was the only one available at the
time the study started, since an Italian version of the
Rome III Questionnaire has not yet been validated, its
items were applicable to both the Rome II and the Rome
III IBS and FD criteria. Therefore, it was possible to diag-
nose IBS on the basis of the Rome III criteria as follows:
abdominal pain or discomfort at least 2 days a week for
the previous 3 months, accompanied by at least 2 of the
following features: (i) it improved with defecation, (ii) it
was associated with a change in the frequency of bowel
movements, (iii) it was associated with a change in the
appearance of the stool. The onset of symptoms had to be
at least 6 months prior to the enrollment. Likewise, FD
was identified in IBS patients if there was at least one of
these symptoms for the previous 3 months: (i) bothersome
postprandial fullness, (ii) early satiation, (iii) epigastric
pain, (iv) epigastric burning. Symptoms had to start at
least 6 months earlier and there had to be no evidence of
a structural disease that was likely to explain them. FD as
defined above was subdivided, following the Rome III defi-
nition, into: 1) postprandial distress syndrome (PDS), con-
sisting of bothersome postprandial fullness (occurring
after an ordinary-sized meal), and/or early satiation (pre-
venting the patient to finish the meal); 2) epigastric pain
syndrome (EPS), consisting of intermittent pain or burning
localized in the epigastric area (i.e. not generalized or loca-
lized in other abdominal or chest regions), not relieved by
defecation or passage of flatus and not fulfilling the criteria
for gallbladder or sphincter of Oddi disorders. No FD
patient was defined as the individual not reporting any
type of dyspeptic symptoms.
Symptom Checklist 90 Revised
Psychopathological features were assessed with
the Symptom Checklist 90 Revised (SCL-90-R) [14], a
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symptoms of psychopathology experienced by indivi-
duals even beyond clinically relevant mental disorders.
The questionnaire is appropriate for use in both nor-
mal and distressed individuals (i.e. individuals with
medical or psychiatric disorders) and has shown good
internal consistency, as well as good inter-rater and
test-retest reliability [14]. Furthermore, it has already
been used in studies on IBS and FD patients, and has
been translated and employed extensively in the Italian
population [15]. Its administration time is approxi-
mately 15 minutes.
The questionnaire consists of 90 items concerning an
individual’s symptom distress in the previous 7 days and
the individual has to assign a score from 0 to 4 depending
on the degree of suffering related to the item: conse-
quently, each item is rated on a five-point Likert scale
(0-4) from “not at all” to “extremely” distressing. In clini-
cal practice, the SCL-90-R is used to reflect a general
symptom level of the individual, i.e. the global severity
index (GSI), as well as a more differentiated subscale pro-
file. The nine subscales that can be derived from the
SCL-90-R are: somatization (SOM, 12 items), obsessive-
compulsive (OBS, 10 items), interpersonal sensitivity
(SENS, 9 items), depression (DEP, 13 items), anxiety
(ANX, 10 items), anger-hostility (HOS, 6 items), phobic
anxiety (PHOB, 7 items), paranoid ideation (PAR, 6
items) and psychoticism (PSYC, 10 items). The final
score of the GSI, which represents the average severity
score of all the 90 items of the questionnaire, is thought
t ob ear e l i a b l em e a s u r eo fp s y c h o l o g i c a ld i s t r e s s .T h e
cut-off score for the GSI used in this study is 0.57, as
indicated by the existing literature [16,17]: scores equal
to or above 0.57 are considered to be indicative of “dys-
functional” subjects (distressed subjects showing symp-
toms of somatic and psychological suffering, whose
severity lies “within a dysfunctional range”), as opposed
to “functional” subjects (healthy subjects, whose symp-
tom severity lies “within a functional range”). “Dysfunc-
tional” subjects have a high probability of psychiatric
disorders. The 9 subscale scores represent the average
score of positively answered items in each subscale.
Statistical analysis
Descriptive statistics as means, medians and standard
deviations were calculated. The non-parametric Mann-
Whitney U test was performed to compare median
scores on the SCL-90-R GSI and subscales in patients
with IBS only and in patients with both IBS and FD, as
well as in IBS patients with PDS and IBS patients with
EPS. A P value of 0.05 or less was regarded as statisti-
cally significant and all reported P values were two-
sided. The SPSS statistical software (version 13.0) [18]
was used for the analyses.
Results
Patients were classified into two groups: patients with IBS
only (n = 56, F = 43, mean age 41.6 ± 13.3 years) and
patients with both IBS and FD (n = 26, F = 24, mean age
41.8 ± 11.5 years). The main demographic and clinical
characteristics of the patients are reported in Table 1. The
psychopathological features of the two groups of patients
were compared using the SCL-90-R. Patients with IBS and
FD showed a significantly higher median score of the GSI
than patients with IBS alone (1.00 (interquartile range:
0.68-1.41) vs 0.48 (0.31-0.91), P = 0.003) (Figure 1).
The group with IBS and FD also scored significantly
higher than the group with IBS alone on eight out of the
nine SCL-90-R subscales: obsessive-compulsive (1.00
(0.60-1.50) vs 0.60 (0.50-0.97), P = 0.03), interpersonal sen-
sitivity (0.89 (0.30-1.55) vs 0.44 (0.13-0.75), P =0 . 0 1 ) ,
depression (1.31 (0.67-1.78) vs 0.61 (0.30-1.00), P = 0.000),
anxiety (1.20 (0.77-1.60) vs 0.65 (0.32-1.10), P = 0.002),
anger-hostility (1.00 (0.33-1.33) vs 0.42 (0.16-0.62), P =
0.02), phobic anxiety (0.14 (0.00-0.75) vs 0.00 (0.00-0.28),
P = 0.02), paranoid ideation (1.25 (0.50-2.00) vs 0.25 (0.00-
0.95), P = 0.000) and psychoticism (0.50 (0.20-1.10) vs 0.20
(0.00-0.40), P = 0.002) (Figure 1). The group with IBS and
FD continued to report significantly higher SCL-90-R GSI
and subscale scores than the group with IBS alone, even
after application of a Holm adjustment for multiple com-
parisons, with the exception of the obsessive-compulsive
subscale (adjusted P value = 0.06). With regard to the two
FD subtypes, of the 26 IBS patients who also fulfilled the
Table 1 Main demographic and clinical characteristics of
patients with IBS and patients with IBS and FD
Disease IBS IBS + FD
N%N %
Gender
Male 13 23.2 2 7.7
Female 43 76.8 24 92.3
Age
<2 0 0 0 0 0
20-29 11 19.6 5 19.2
30-39 18 32.1 6 23.1
40-49 11 19.6 8 30.8
50-59 7 12.6 5 19.2
60-69 9 16.1 2 7.7
≥ 70 0 0 0 0
Type of referral
Self-referral 19 33.9 9 34.6
Primary care 30 53.6 15 57.7
Other gastroenterologists 7 12.5 2 7.7
Total 56 100 26 100
IBS = irritable bowel syndrome; FD = functional dyspepsia.
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± 12.0 years) and 9 had EPS (34.6%, F = 8, mean age 45.0
± 11.0 years). No difference was found in the median
scores of the SCL-90-R GSI and subscales between IBS
patients with PDS and IBS patients with EPS (P ranging
from 0.07 to 0.97).
Discussion
IBS and FD are highly prevalent in the general population
and they frequently occur simultaneously, with a high
percentage of patients satisfying diagnostic criteria for
both disorders. The estimated prevalence of FD in IBS
patients ranges between 56% and 87% in population-
based studies [3,19], while the same analysis performed
on gastroenterological outpatients shows percentages
ranging between 66% and 87% [5,8,20,21]. On the other
hand, dyspeptic subjects match the symptom-based diag-
nosis of IBS in 14%-29% of cases in community-based
settings [22,23] and in 13%-46% of cases in patient-based
series [6,24,25]. The high variability of IBS and FD
co-occurrence rates across studies may be attributed to
differences in the geographical origin of the studied
population [5], in the size of the patient sample [5,26]
and in the applied diagnostic criteria (standardized Rome
criteria versus diagnoses based on clinical opinion; Rome
III criteria versus Rome II or Rome I criteria) [5,26].
The frequencies of IBS-FD overlap observed across stu-
dies are two to three times higher than those expected
from the analysis of the prevalence of each condition in
t h ep o p u l a t i o n .T h e s ed a t ap o i n tt oar e l a t i o n s h i p
b e t w e e nI B Sa n dF Dt h a tc a n n o tb ee x p l a i n e db yt h e
pure chance occurrence of the two disorders, albeit both
very common [26], suggesting instead a possible shared
pathopyhisiology [5,25]. Overlap between IBS and upper
gastrointestinal symptoms can be observed in both FD
subtypes, PDS and EPS, with the former showing a higher
chance of overlap with IBS than the latter [5].
T h ep r e s e n ts t u d ys h o w sah i g hf r e q u e n c yo fo v e r l a p
between IBS and FD, equal to 31.7%, supporting previous
findings [2,25]. Moreover, it shows no difference in terms
of IBS-FD overlap between PDS and EPS, but this result
should be interpreted with caution, considering the small
sample size of the two subgroups.
IBS and FD are both associated with psychiatric symp-
toms and disorders [6,7]. It is widely recognized that IBS
patients have a higher prevalence of psychopathology
(40%-60% of subjects) - notably anxiety, depression, panic,
post-traumatic stress and somatization [7,27] - in compar-
ison with patients affected by organic gastrointestinal dis-
orders (< 25% of subjects) and healthy controls (< 20% of
subjects) [7,28]. Compared to IBS, data on psychiatric
comorbidity in FD are scarce. FD patients, like IBS
patients, show a high prevalence of psychopathology (35%-
86% of subjects), in particular anxiety, depression, somati-
zation and alexithymia [29-31]. The prevalence rates are
higher than those reported for patients affected by organic
dyspepsia (25% of subjects) and healthy controls (< 20% of
subjects) [32,33]. To our knowledge, there is only one
study [34] which has evaluated psychological factors in FD
using the Rome III definition and distinguishing between
the two FD subtypes: this study has found that anxiety is
linked to PDS, but not to EPS, and that depression is not
linked to either of them.
There appear to be similarities in the frequency and type
of psychiatric comorbidity in IBS and FD [35], but psycho-
logical factors are not believed to be an essential underly-
ing cause for either of them: in accordance with the
biopsychosocial model of functional gastrointestinal disor-
ders [36], psychological factors, through their interaction
with biological and social factors, influence the clinical
expression and outcome of these disorders [37], thus
determining health-care services utilization [11] and
health-related quality of life [7].
It is not well understood whether the overlap between
lower and upper gastrointestinal symptoms in IBS
patients, which is known to increase the overall gastroin-
testinal symptom severity [25], is also associated with an
increased level of psychopathology. In recent studies on
IBS patients, coexisting upper gastrointestinal symptoms,
compatible with the diagnosis of FD, seem to increase the
level of psychopathology [8,9]. A study by Talley et al.[ 8 ]
reports a statistically significant positive correlation
between the SCL-90-R GSI and the number of gastroin-
testinal symptoms in IBS patients with upper gastrointest-
inal symptoms. A subsequent study by Balboa et al.[ 9 ]
shows that the presence of FD in IBS patients has a signifi-
cant negative impact on the psychological status. On the
Figure 1 Line graph comparing median scores of the SCL-90-R
GSI and subscales between patients with IBS and patients with
IBS and FD. IBS = irritable bowel syndrome; FD = functional
dyspepsia; GSI = global severity index; SOM = somatization; OBS =
obsessive-compulsive; SENS = interpersonal sensitivity; DEP =
depression; ANX = anxiety; HOS = anger-hostility; PHOB = phobic
anxiety; PAR = paranoid ideation; PSYC = psychoticism. (*) = P ≤
0.05; (**) = P ≤ 0.01; (***) = P ≤ 0.001.
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has found that the number of comorbid functional gastro-
intestinal disorders does not correlate with higher scores
for anxiety and depression.
The present study shows that patients meeting the
Rome III diagnostic criteria for both IBS and FD have a
greater severity of psychopathological symptoms than
those with IBS only, rating significantly higher on the GSI
and on eight out of the nine SCL-90-R subscales: obses-
sive-compulsive, interpersonal sensitivity, depression, anxi-
ety, anger-hostility, phobic anxiety, paranoid ideation and
psychoticism. Moreover, only the group of patients with
both IBS and FD presents a median score of the GSI >
0.57, the cut-off point above which patients are considered
“dysfunctional” (i.e. with a high probability of psychiatric
disorders) [16,17]. The results of this study are in accor-
dance with those obtained by Talley et al. [8] and Balboa
et al. [9], which used the Rome II diagnostic criteria. The
present study applied the Rome III criteria and assessed
the association of psychopathological features with IBS-FD
overlap, differently from Mikocka-Walus et al.[ 1 0 ] ,w h o
have not investigated patients with IBS-FD overlap, but
rather a small size population with any type of functional
gastrointestinal disorder.
The findings of this study are not surprising: given the
strong link between IBS, FD, and psychiatric comorbidity,
it seems likely that patients with more gastrointestinal
symptoms have also more - or more severe - psychiatric
symptoms. The higher prevalence of hypersensitivity to
gastric distension observed in patients with both IBS and
FD in comparison to patients with IBS or FD only [25]
could be a pathophysiological mechanism capable of
explaining the difference not only in the severity of gastro-
intestinal symptoms, but also, hypothetically, in the sever-
ity of the psychological suffering.
It is not known whether this effect is different between
IBS patients with PDS and IBS patients with EPS. Accord-
ing to recent studies, FD appears to include different types
of patients with distinct underlying pathophysiologies who
require different management [2,12]. Since functional
gastrointestinal disorders are viewed as multifactorial
disorders in which physiological, psychological and social
factors are strictly intertwined [7], different FD subtypes
may differ not only in pathophysiology, but also in psycho-
pathology. As a preliminary analysis, the present study
compared psychopathological features between IBS
patients with PDS and IBS patients with EPS, showing
that these two subgroups of patients are characterized by
comparable scores on the SCL-90-R GSI and subscales.
However, given the small size of the two subgroups, the
lack of significant findings may be due to a lack of statisti-
cal power to identify differences: these findings have to be
considered provisional and should be confirmed in a larger
population sample. For this reason, we are testing these
observations in a new study in which we are increasing the
sample size.
In the present study, 11.0% of patients were referred
from other gastroenterologists. It could be argued that
these patients may behave differently from primary care-
or self-referred patients, but we found that they did not
differ by any demographic or psychological variable. In
any case, some bias cannot be ruled out and our third
level referral centre sample may not accurately represent
the entire population of patients with IBS or with IBS
and FD.
To conclude, in clinical practice the higher levels of psy-
chopathology observed in IBS patients with FD in compari-
son to those without FD may result in an increased
medical consultation and in a greater impairment of
health-related quality of life, with significant socio-eco-
nomic implications. According to Hu et al. [38], coexisting
depression and anxiety act as catalysts for IBS patients to
seek medical care, thus increasing the socio-economic bur-
den of this functional gastrointestinal disorder. The pre-
sence of FD in IBS patients, by causing more severe
depressive and anxiety symptoms, may exacerbate this
effect.
Conclusions
Approximately one-third of IBS patients recruited in this
study fulfill the Rome III criteria for FD. IBS patients
with FD show significantly higher scores on the SCL-90-
R GSI and subscales than IBS patients without FD, sup-
porting the hypothesis that the presence of FD in addi-
tion to IBS is associated with an increased severity of
psychopathological features. These findings suggest that
a substantial subset of patients of a third level gastroen-
terological referral centre presenting both IBS and FD
symptoms may benefit from psychological assessment
and treatment. Appropriate assessment and treatment
are likely to have a positive impact on patients’ well-
being and health care utilization.
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